BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will sit on a panel at the 2007 BIO International Convention titled "Mining for Gold: Top Biotech Venture Capital Markets" in Boston
News | 05. 06. 2007
